Distalmotion

Distalmotion is a privately held medical device company headquartered in Lausanne, Switzerland, with a mission to empower access to robotic surgery by removing operational barriers. The company's flagship product, the DEXTER Robotic Surgery System, is designed for seamless integration into existing operating room workflows, enabling more surgeons across more care sites to perform robotic procedures. Having received CE mark in 2020 and FDA clearances for specific procedures, DEXTER is now in clinical use, treating patients daily. The company employs over 150 people from more than 25 nationalities, united in bringing best-in-class minimally invasive surgical care to patients worldwide.

The DEXTER Robotic Surgery System is a modular, hybrid platform designed to simplify robotic-assisted minimally invasive surgery by integrating seamlessly into existing operating room workflows, allowing surgeons to switch between laparoscopic and robotic techniques.

Distalmotion competes in the surgical robotics market dominated by Intuitive Surgical. Its main differentiation is focused on simplifying operations and reducing workflow disruption to enable access in more care settings, contrasting with larger, more complex systems. It also faces competition from other new entrants like Medtronic, Johnson & Johnson, and CMR Surgical.